CONTEXT: Estimates of DSM-IV disorder prevalence are high; stringent criteria to define need for services are desired. OBJECTIVE: To present US national data on the prevalence and sociodemographic correlates of 12-month serious emotional disturbance (SED), defined by the US Substance Abuse and Mental Health Services Administration, from the National Comorbidity Survey Replication Adolescent Supplement. DESIGN: The National Comorbidity Survey Replication Adolescent Supplement is a national survey of DSM-IV anxiety, mood, behavior, and substance disorders among US adolescents. SETTING: Dual-frame household and school samples of US adolescents. PARTICIPANTS: Total of 6483 pairs of adolescents aged 13 to 17 (interviews) and parents (questionnaires). MAIN OUTCOME MEASURES: The DSM-IV disorders were assessed with the World Health Organization Composite International Diagnostic Interview and validated with blinded clinical interviews based on the Schedule for Affective Disorders and Schizophrenia for School-Age Children. Serious emotional disturbance was operationalized as a DSM-IV/Composite International Diagnostic Interview disorder with a score of 50 or less on the Children's Global Assessment Scale (ie, moderate impairment in most areas of functioning or severe impairment in at least 1 area). Concordance of Composite International Diagnostic Interview SED diagnoses with blinded Schedule for Affective Disorders and Schizophrenia for School-Age Children diagnoses was good. RESULTS: The estimated prevalence of SED was 8.0%. Most SEDs were due to behavior (54.5%) or mood (31.4%) disorders. Although respondents with 3 or more disorders made up only 29.0% of those with 12-month DSM-IV/Composite International Diagnostic Interview disorders, they constituted 63.5% of SEDs. Predictive effects of high comorbidity were significantly greater than the product of their disorder-specific odds ratios and consistent across disorder types. Associations of sociodemographic variables with SED were generally nonsignificant after controlling for disorder type and number. CONCLUSIONS: The high estimated 12-month prevalence of DSM-IV disorders among US adolescents is largely due to mild cases. The significant between-disorder differences in risk of SED and the significant effect of high comorbidity have important public health implications for targeting interventions.
CONTEXT: Estimates of DSM-IV disorder prevalence are high; stringent criteria to define need for services are desired. OBJECTIVE: To present US national data on the prevalence and sociodemographic correlates of 12-month serious emotional disturbance (SED), defined by the US Substance Abuse and Mental Health Services Administration, from the National Comorbidity Survey Replication Adolescent Supplement. DESIGN: The National Comorbidity Survey Replication Adolescent Supplement is a national survey of DSM-IV anxiety, mood, behavior, and substance disorders among US adolescents. SETTING: Dual-frame household and school samples of US adolescents. PARTICIPANTS: Total of 6483 pairs of adolescents aged 13 to 17 (interviews) and parents (questionnaires). MAIN OUTCOME MEASURES: The DSM-IV disorders were assessed with the World Health Organization Composite International Diagnostic Interview and validated with blinded clinical interviews based on the Schedule for Affective Disorders and Schizophrenia for School-Age Children. Serious emotional disturbance was operationalized as a DSM-IV/Composite International Diagnostic Interview disorder with a score of 50 or less on the Children's Global Assessment Scale (ie, moderate impairment in most areas of functioning or severe impairment in at least 1 area). Concordance of Composite International Diagnostic Interview SED diagnoses with blinded Schedule for Affective Disorders and Schizophrenia for School-Age Children diagnoses was good. RESULTS: The estimated prevalence of SED was 8.0%. Most SEDs were due to behavior (54.5%) or mood (31.4%) disorders. Although respondents with 3 or more disorders made up only 29.0% of those with 12-month DSM-IV/Composite International Diagnostic Interview disorders, they constituted 63.5% of SEDs. Predictive effects of high comorbidity were significantly greater than the product of their disorder-specific odds ratios and consistent across disorder types. Associations of sociodemographic variables with SED were generally nonsignificant after controlling for disorder type and number. CONCLUSIONS: The high estimated 12-month prevalence of DSM-IV disorders among US adolescents is largely due to mild cases. The significant between-disorder differences in risk of SED and the significant effect of high comorbidity have important public health implications for targeting interventions.
Authors: Ronald C Kessler; Shelli Avenevoli; E Jane Costello; Katholiki Georgiades; Jennifer Greif Green; Michael J Gruber; Jian-ping He; Doreen Koretz; Katie A McLaughlin; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Kathleen Ries Merikangas Journal: Arch Gen Psychiatry Date: 2011-12-05
Authors: Ronald C Kessler; Kathleen R Merikangas; Patricia Berglund; William W Eaton; Doreen S Koretz; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2003-11
Authors: E B Braaten; J Biederman; A DiMauro; E Mick; M C Monuteaux; K Muehl; S V Faraone Journal: J Child Adolesc Psychopharmacol Date: 2001 Impact factor: 2.576
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Ronald C Kessler; Shelli Avenevoli; E Jane Costello; Katholiki Georgiades; Jennifer Greif Green; Michael J Gruber; Jian-ping He; Doreen Koretz; Katie A McLaughlin; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Kathleen Ries Merikangas Journal: Arch Gen Psychiatry Date: 2011-12-05
Authors: Yael Dvir; Jean A Frazier; Robert M Joseph; Irina Mokrova; Phoebe S Moore; T Michael OʼShea; Stephen R Hooper; Hudson P Santos; Karl Kuban Journal: J Dev Behav Pediatr Date: 2019-12 Impact factor: 2.225
Authors: Emma K Adam; Suzanne Vrshek-Schallhorn; Ashley D Kendall; Susan Mineka; Richard E Zinbarg; Michelle G Craske Journal: Psychoneuroendocrinology Date: 2014-03-12 Impact factor: 4.905
Authors: Nicholas Peiper; Richard Clayton; Richard Wilson; Robert Illback; Elizabeth O'Brien; Richard Kerber; Richard Baumgartner; Carlton Hornung Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2015-02-05 Impact factor: 4.328
Authors: Sanita L Hunsaker; Beth H Garland; Dana Rofey; Jennifer Reiter-Purtill; James Mitchell; Anita Courcoulas; Todd M Jenkins; Meg H Zeller Journal: J Adolesc Health Date: 2018-04-30 Impact factor: 5.012